Sandbox Reserved 321
From Proteopedia
(Difference between revisions)
Line 4: | Line 4: | ||
- | '''InhA''' | + | ='''InhA'''= |
by Kelly Hrywkiw | by Kelly Hrywkiw | ||
{{STRUCTURE_2h9i | PDB=2h9i | SCENE= }} | {{STRUCTURE_2h9i | PDB=2h9i | SCENE= }} | ||
+ | |||
+ | ==Introduction== | ||
+ | |||
+ | InhA is a enoyl-acyl ACP carrier protein that plays a role in the sysnthesis of Mycolic Acid <ref name="mech of thioamide drug action"/> | ||
+ | |||
+ | ==Structure== | ||
+ | |||
+ | ==Physiological Function== | ||
+ | |||
+ | ==Role in the Mycolic Acid Pathway== | ||
+ | |||
+ | ==Protein Superfamilly== | ||
+ | |||
+ | ==References== | ||
+ | <Wang F., Langley R., Gulten G., Dover L. G., Besra G. S., Jacobs W. R., and Sacchettini J. C., 2007. The Journal of Experimental Medicine. 204(1) 73-78="mech of thioamide drug action"/> |
Revision as of 18:51, 30 March 2011
This Sandbox is Reserved from January 10, 2010, through April 10, 2011 for use in BCMB 307-Proteins course taught by Andrea Gorrell at the University of Northern British Columbia, Prince George, BC, Canada. |
To get started:
More help: Help:Editing |
Contents |
InhA
by Kelly Hrywkiw
| |||||||||
2h9i, resolution 2.20Å () | |||||||||
---|---|---|---|---|---|---|---|---|---|
Ligands: | |||||||||
Gene: | inhA (Mycobacterium tuberculosis) | ||||||||
Activity: | [acyl-carrier-protein_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number 1.3.1.9 | ||||||||
Related: | 1zid | ||||||||
| |||||||||
| |||||||||
Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||||
Coordinates: | save as pdb, mmCIF, xml |
Introduction
InhA is a enoyl-acyl ACP carrier protein that plays a role in the sysnthesis of Mycolic Acid [1]
Structure
Physiological Function
Role in the Mycolic Acid Pathway
Protein Superfamilly
References
<Wang F., Langley R., Gulten G., Dover L. G., Besra G. S., Jacobs W. R., and Sacchettini J. C., 2007. The Journal of Experimental Medicine. 204(1) 73-78="mech of thioamide drug action"/>